Long Ma
Capital Medical University
5 Papers
1 Citations
Long Ma is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke.
Yimeng Xue,Ding Nie,Lin-jian Wang,Lin-jian Wang,Han-Cheng Qiu,Long Ma,Ming-Xin Dong,Wen-Jun Tu,Wen-Jun Tu,Jizong Zhao +9 more
TL;DR: In this paper, the authors discuss the process of microglial polarization, summarize the alternation of signaling pathways and epigenetic regulation that control microglia polarization in ischemic stroke, aiming to find the potential mechanisms by which microglias can be transformed into the M2 polarized phenotype.
99
Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques
Peicong Ge,Haochen Li,Xiaolong Ya,Yi-lin Xu,Long Ma,Qiheng He,Rong Wang,Zechen Liu,Qing Zhang,Yan Zhang,Wenjing Wang,Dong Zhang,Jizong Zhao +12 more
TL;DR: Wang et al. as mentioned in this paper performed RNA-sequencing on superficial temporal arteries from 5 traumatic patients and plaques from 3 atherosclerotic patients to preliminary identify the key immune response processes in plaques.
Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients
Xiaolong Ya,Long Ma,Chenglong Liu,Peicong Ge,Yiqiao Xu,Zhiyao Zheng,Siqi Mou,Rong Wang,Qian Zhang,Xun Ye,Dong Zhang,Yan Zhang,Wenjing Wang,Haochen Li,Jizong Zhao +14 more
TL;DR: The constructed aneurysm occurrence model and an aneurysm growth model could precisely identify patients with IAs with high prediction accuracy and exhibited superiority over ELAPSS scores in predicting aneurysm growth (lower prediction errors and out‐of‐bag errors).
2
Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)
Peicong Ge,Zihan Yin,Chuming Tao,Chaofan Zeng,Xiaofan Yu,Shixiong Lei,Junsheng Li,Yu Zhai,Long Ma,Qiheng He,Chenglong Liu,Wei Liu,Bojian Zhang,Zhiyao Zheng,Siqi Mou,Zhikang Zhao,Shuang Wang,Wei Sun,Min Guo,Shuai Zheng,J. Zhang,Xiaofeng Deng,Xingju Liu,Xun Ye,Qian Zhang,Rong Wang,Yan Zhang,Shao-Sen Zhang,Chengjun Wang,Ziwen Yang,Nijia Zhang,Mingxing Wu,Jian Sun,Yujia Zhou,Zhiyong Shi,Yong-Sheng Ma,Jianpo Zhou,Shaochen Yu,Jiaxi Li,Junli Lu,Faliang Gao,Wenjing Wang,Yanming Chen,Xingen Zhu,Dong Zhang,Jizong Zhao +45 more
TL;DR: The MOYAOMICS project represents a significant step toward comprehending MMD’s molecular underpinnings, and has the potential to revolutionize early diagnosis, patient stratification, and the development of targeted therapies for MMD.
2
Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease
TL;DR: Different infarction patterns on DWI imply different risks of recurrent ACEs, and more attention should be paid to prevent ACEs in MMD patients with MAIs.